Qing Xu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Health Information

Top Venues

JMIR formative research

Cancer gene therapy

Science advances

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Chen-Xu Ni, Yi-Fu Wang, Yun-Ting Zhang, Min Yuan, Qing Xu, Fu-Ming Shen, Dong-Jie Li, Fang Huang
A Mobile Applet for Assessing Medication Adherence and Managing Adverse Drug Reactions Among Patients With Cancer: Usability and Utility Study. JMIR formative research 8 (2024)
Chen-Xu Ni, Yi-Fu Wang, Yun-Ting Zhang, Min Yuan, Qing Xu, Fu-Ming Shen, Dong-Jie Li, Fang Huang
A Mobile Applet for Assessing Medication Adherence and Managing Adverse Drug Reactions Among Patients With Cancer: Usability and Utility Study. JMIR formative research 8 (2024)
Chen-Xu Ni, Yi-Fu Wang, Yun-Ting Zhang, Min Yuan, Qing Xu, Fu-Ming Shen, Dong-Jie Li, Fang Huang
A Mobile Applet for Assessing Medication Adherence and Managing Adverse Drug Reactions Among Patients With Cancer: Usability and Utility Study. JMIR formative research 8 (2024)
Chen-Xu Ni, Yi-Fu Wang, Yun-Ting Zhang, Min Yuan, Qing Xu, Fu-Ming Shen, Dong-Jie Li, Fang Huang
A Mobile Applet for Assessing Medication Adherence and Managing Adverse Drug Reactions Among Patients With Cancer: Usability and Utility Study. JMIR formative research 8 (2024)
Dan Li, Xianling Guo, Kun Yang, Yuening Yang, Weilin Zhou, Yong Huang, Xiao Liang, Jinhua Su, Lin Jiang, Jing Li, Maorong Fu, Haixia He, Jinrong Yang, Hua-Shan Shi, Hanshuo Yang, Aiping Tong, Nianyong Chen, Jian-Kun Hu, Qing Xu, Yu-Quan Wei, Wei Wang
EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors. Science advances 9 (48) (2023)
Rui Ma, Xiaolin Chu, Yiting Jiang, Qing Xu
Pigment epithelium-derived factor, an anti-VEGF factor, delays ovarian cancer progression by alleviating polarization of tumor-associated macrophages. Cancer gene therapy 29 (10) (2022)
Yuzhen Yin, Pengchao Zhang, Ling He, Xianling Guo, Hui Wang, Jun Li, Qing Xu
Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)